244 related articles for article (PubMed ID: 24373905)
1. Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition.
Carr RL; Graves CA; Mangum LC; Nail CA; Ross MK
Neurotoxicology; 2014 Jul; 43():82-89. PubMed ID: 24373905
[TBL] [Abstract][Full Text] [Related]
2. Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development.
Carr RL; Armstrong NH; Buchanan AT; Eells JB; Mohammed AN; Ross MK; Nail CA
Neurotoxicology; 2017 Mar; 59():183-190. PubMed ID: 26642910
[TBL] [Abstract][Full Text] [Related]
3. Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure.
Carr RL; Adams AL; Kepler DR; Ward AB; Ross MK
Toxicol Sci; 2013 Sep; 135(1):193-201. PubMed ID: 23761300
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats.
Buntyn RW; Alugubelly N; Hybart RL; Mohammed AN; Nail CA; Parker GC; Ross MK; Carr RL
Int J Toxicol; 2017; 36(5):395-402. PubMed ID: 28820005
[TBL] [Abstract][Full Text] [Related]
5. Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats.
Carr RL; Borazjani A; Ross MK
Toxicol Sci; 2011 Jul; 122(1):112-20. PubMed ID: 21507991
[TBL] [Abstract][Full Text] [Related]
6. The mechanistic basis for the toxicity difference between juvenile rats and mice following exposure to the agricultural insecticide chlorpyrifos.
Sette KN; Alugubelly N; Glenn LB; Guo-Ross SX; Parkes MK; Wilson JR; Seay CN; Carr RL
Toxicology; 2022 Oct; 480():153317. PubMed ID: 36096317
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum.
Liu J; Parsons L; Pope C
Neurotoxicology; 2015 Sep; 50():20-7. PubMed ID: 26215119
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity.
Liu J; Parsons L; Pope C
Toxicol Appl Pharmacol; 2013 Nov; 272(3):608-15. PubMed ID: 23933531
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice.
Kondakala S; Lee JH; Ross MK; Howell GE
Toxicol Appl Pharmacol; 2017 Dec; 337():67-75. PubMed ID: 29097212
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
Timchalk C; Poet TS; Kousba AA
Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
Liu J; Pope C
Neurotoxicology; 2015 Jan; 46():12-8. PubMed ID: 25447325
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison.
Chanda SM; Mortensen SR; Moser VC; Padilla S
Fundam Appl Toxicol; 1997 Aug; 38(2):148-57. PubMed ID: 9299188
[TBL] [Abstract][Full Text] [Related]
13. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
14. Lack of differential sensitivity to cholinesterase inhibition in fetuses and neonates compared to dams treated perinatally with chlorpyrifos.
Mattsson JL; Maurissen JP; Nolan RJ; Brzak KA
Toxicol Sci; 2000 Feb; 53(2):438-46. PubMed ID: 10696792
[TBL] [Abstract][Full Text] [Related]
15. Changes in rat brain cholinesterase activity and muscarinic receptor density during and after repeated oral exposure to chlorpyrifos in early postnatal development.
Tang J; Carr RL; Chambers JE
Toxicol Sci; 1999 Oct; 51(2):265-72. PubMed ID: 10543028
[TBL] [Abstract][Full Text] [Related]
16. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats.
Zheng Q; Olivier K; Won YK; Pope CN
Toxicol Sci; 2000 May; 55(1):124-32. PubMed ID: 10788567
[TBL] [Abstract][Full Text] [Related]
17. Persistent proteomic changes in glutamatergic and GABAergic signaling in the amygdala of adolescent rats exposed to chlorpyrifos as juveniles.
Alugubelly N; Mohammed AN; Carr RL
Neurotoxicology; 2021 Jul; 85():234-244. PubMed ID: 34058248
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.
Nallapaneni A; Liu J; Karanth S; Pope C
Neurotoxicology; 2008 Nov; 29(6):1037-43. PubMed ID: 18765251
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase.
Bushnell PJ; Pope CN; Padilla S
J Pharmacol Exp Ther; 1993 Aug; 266(2):1007-17. PubMed ID: 7689099
[TBL] [Abstract][Full Text] [Related]
20. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
Bushnell PJ; Kelly KL; Ward TR
J Pharmacol Exp Ther; 1994 Jul; 270(1):15-25. PubMed ID: 7518512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
